330-Patient Cohort Tracks Baricitinib Long-Term in Alopecia Areata
A single-center JAAD cohort of 330 patients reports long-term baricitinib outcomes in alopecia areata, totalis and universalis, with regrowth tracked by serial trichoscopy monitoring.